Rein Therapeutics

1. admilparant BMS Ph3 topline2H 2026admilparant BMS Ph3 topline, 2H 2026, material
2. LTI-03 Ph2 interim4Q 2026LTI-03 Ph2 interim, 4Q 2026, notable
3. RNTX Bios corporate updateOct 27, 2026RNTX Bios corporate update, Oct 27, 2026, routine
4. RNTX listing updateFeb 17, 2027RNTX listing update, Feb 17, 2027, routine
5. Tyvaso nebulized PDUFA dateApr 2027Tyvaso nebulized PDUFA date, Apr 2027, material
6. TETON-1/-2 United Therapeutics PDUFA dateApr 2027TETON-1/-2 United Therapeutics PDUFA date, Apr 2027, material
7. ASPIRE Vicore Ph2b toplineMid-2027ASPIRE Vicore Ph2b topline, Mid-2027, material
8. RNTX legacy warrants corporate updateMay 2027RNTX legacy warrants corporate update, May 2027, routine
9. MIST Avalyn Ph2b topline2H 2027MIST Avalyn Ph2b topline, 2H 2027, material

Bar width shows how precise the guidance is — a pin is a stated date, a wide band a six-month window. Deeper blue means more of the thesis rides on the event; it is not a view on the stock.